Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Advanced Magnetics in-licenses contrast agent from Andaris

March 10, 1998

No Comments

Matritech: Q4 and year-end 1997 highlights

March 6, 1998

No Comments

Cytogen: Q4 and year-end 1997 highlights

March 4, 1998

No Comments

FDA requests additional information for EchoGen NDA review

March 2, 1998

No Comments

UroGenesys licenses prostate cancer gene for diagnostic and therapeutic development

Feb. 27, 1998

No Comments

Thyrogen will receive priority review by the FDA; EU application also accepted

Feb. 26, 1998

No Comments

Diatide issued approvable letter for AcuTect by FDA

Feb. 24, 1998

No Comments

Company Profile: Mallinckrodt

Feb. 20, 1998

No Comments

Guilford: FY 1997 highlights

Feb. 18, 1998

No Comments

Immunomedics terminates CEA-Scan marketing agreements with Mallinckrodt

Feb. 12, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Diagnostics, BioWorld Science
RSS

Advanced Magnetics in-licenses contrast agent from Andaris

Matritech: Q4 and year-end 1997 highlights

Cytogen: Q4 and year-end 1997 highlights

FDA requests additional information for EchoGen NDA review

UroGenesys licenses prostate cancer gene for diagnostic and therapeutic development

Thyrogen will receive priority review by the FDA; EU application also accepted

Diatide issued approvable letter for AcuTect by FDA

Company Profile: Mallinckrodt

Guilford: FY 1997 highlights

Immunomedics terminates CEA-Scan marketing agreements with Mallinckrodt

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Diagnostics, BioWorld Science RSS

Diagnostics, BioWorld Science
RSS